In addition, both DPP4 and CTCF have been proposed to participate in NAFLD, and we speculated that they might work in concert to induce multiple biological processes that promote the pathogenesis of NAFLD, and their synergy might be the target where gardenoside exerts its anti-NAFLD effects. Here, CTCF is linked to metabolic dysfunction-associated steatotic liver disease.